Skip to main content
Log in

Heart, Liver, and Pancreas MRI Evaluation of Iron Overload

  • MRI for Pediatric Oncology (H Lederman, Section Editor)
  • Published:
Current Radiology Reports Aims and scope Submit manuscript

Abstract

Although the human body has a very well-controlled absorption of iron, it has no effective form of excretion. Excess iron can lead to toxicity because this element can catalyze the conversion of hydrogen peroxide into free radicals, causing damage to the cell membranes, proteins, and DNA. There is a great concern about persistent long-term myocardial iron overload which can lead to cardiomyopathy and heart failure. Also, in the liver, it increases the risk of fibrosis, cirrhosis, and hepatoma. The signs and symptoms of iron overload are highly nonspecific, and using clinical criteria, it is impossible to predict, at an early stage, which patients are at high risk of dying from iron-related heart failure. The measurement of plasma ferritin provides an indirect estimate of total body iron stores, but the usefulness of this measurement is limited by many common clinical conditions such as inflammation, fever, and liver disease; also, it does not reflect myocardial iron overload. By the other hand, magnetic resonance imaging is a robust noninvasive method to detect tissue iron overload, allowing early diagnosis and treatment, improving survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19:205–66.

    Article  CAS  PubMed  Google Scholar 

  2. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256–62.

    Article  CAS  PubMed  Google Scholar 

  3. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986–95.

    Article  CAS  PubMed  Google Scholar 

  4. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, Sabato V, Melevendi C, Cappellini MD, Verlato G. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227–31.

    Article  CAS  PubMed  Google Scholar 

  5. Kaikov Y, Wadsworth LD, Hassall E, Dimmick JE, Rogers PC. Primary hemochromatosis in children: report of three newly diagnosed cases and review of the pediatric literature. Pediatrics. 1992;90:37–42.

    CAS  PubMed  Google Scholar 

  6. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the uk and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging. 2005;21:531–8.

    Article  PubMed  Google Scholar 

  8. Westwood MA, Anderson LJ, Firmin DN, Gatehouse PD, Lorenz CH, Wonke B, Pennell DJ. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging. 2003;18:616–20.

    Article  PubMed  Google Scholar 

  9. Brasch RC, Wesbey GE, Gooding CA, Koerper MA. Magnetic resonance imaging of transfusional hemosiderosis complicating thalassemia major. Radiology. 1984;150:767–71.

    Article  CAS  PubMed  Google Scholar 

  10. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based mr imaging and its special applications. Radiographics. 2009;29:1433–49.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding for an improved mri iron quantification. NMR Biomed. 2004;17:427–32.

    Article  CAS  PubMed  Google Scholar 

  12. Wood JC, Ghugre N. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008;32:85–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.

    Article  CAS  PubMed  Google Scholar 

  14. Leonardi B, Margossian R, Colan SD, Powell AJ. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging. 2008;1:572–8.

    Article  PubMed  Google Scholar 

  15. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging. 2003;18:33–9.

    Article  PubMed  Google Scholar 

  16. •• Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJ. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28. This study was the first to direct correlate cardiac Iron concentration measured quantitatively in situ (full myocardium specimens) with T2* measurements in/ex-vivo, providing calibration curves.

  17. He T, Kirk P, Firmin DN, Lam WM, Chu WC, Au WY, Chan GC, Tan RS, Ng I, Biceroglu S, Aydinok Y, Fogel MA, Cohen AR, Pennell DJ. Multi-center transferability of a breath-hold t2 technique for myocardial iron assessment. J Cardiovasc Magn Reson. 2008;10:11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M. Multicenter validation of the magnetic resonance T2* technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging. 2009;30:62–8.

    Article  PubMed  Google Scholar 

  19. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW, Au WY, Chu WC, Chan G, Galanello R, Matta G, Fogel M, Cohen AR, Tan RS, Chen K, Ng I, Lai A, Fucharoen S, Laothamata J, Chuncharunee S, Jongjirasiri S, Firmin DN, Smith GC, Pennell DJ. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32:315–9.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Alpendurada F, Carpenter JP, Deac M, Kirk P, Walker JM, Porter JB, Banya W, He T, Smith GC, Pennell DJ. Relation of myocardial T2* to right ventricular function in thalassaemia major. Eur Heart J. 2010;31:1648–54.

    Article  PubMed  Google Scholar 

  22. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R. Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 2006;107:3738–44.

    Article  CAS  PubMed  Google Scholar 

  23. Alpendurada F, Smith GC, Carpenter JP, Nair SV, Tanner MA, Banya W, Dessi C, Galanello R, Walker JM, Pennell DJ. Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major. J Cardiovasc Magn Reson. 2012;14:8.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother. 2001;55:333–9.

    Article  CAS  PubMed  Google Scholar 

  25. • Kew MC. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer. 2014;3:31–40. Review article that discusses the causes for Iron overload and its deleterious effects in the liver.

  26. Gandon Y, Guyader D, Heautot JF, Reda MI, Yaouanq J, Buhe T, Brissot P, Carsin M, Deugnier Y. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo mr imaging. Radiology. 1994;193:533–8.

    Article  CAS  PubMed  Google Scholar 

  27. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363:357–62.

    Article  CAS  PubMed  Google Scholar 

  28. Christoforidis A, Perifanis V, Spanos G, Vlachaki E, Economou M, Tsatra I, Athanassiou-Metaxa M. Mri assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations. Eur J Haematol. 2009;82:388–92.

    Article  PubMed  Google Scholar 

  29. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE, Hillenbrand CM. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113:4853–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Storey P, Thompson AA, Carqueville CL, Wood JC, de Freita RA, Rigsby CK. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging. 2007;25:540–7.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Papakonstantinou O, Ladis V, Kostaridou S, Maris T, Berdousi H, Kattamis C, Gourtsoyiannis N. The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur Radiol. 2007;17:1535–43.

    Article  PubMed  Google Scholar 

  33. Noetzli LJ, Papudesi J, Coates TD, Wood JC. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood. 2009;114:4021–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. • de Assis RA, Ribeiro AA, Kay FU, Rosemberg LA, Nomura CH, Loggetto SR, Araujo AS, Fabron Junior A, de Almeida Verissimo MP, Baldanzi GR, Esposito BP, Baroni RH, Wood JC, Hamerschlak N. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients. Eur J Radiol. 2012;81:1465–1470. This study demonstrated that pancreatic T2* and cardiac T2* are correlated, but neither were correlated with liver T2*, suggesting that the first two organs may share a common pathophysiological pathway to cope with Iron overload. Furthermore, lower pacreatic T2* was correlated with diabetes, corroborating the hypothesis that Iron deposition in the tissues is toxic, and that in the case of the pancreas, may be the culprit of beta-cell failure.

  35. Au WY, Lam WW, Chu W, Tam S, Wong WK, Liang R, Ha SY. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93:116–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilberto Szarf.

Additional information

This article is part of the Topical Collection on MRI for Pediatric Oncology.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szarf, G., Kay, F.U. Heart, Liver, and Pancreas MRI Evaluation of Iron Overload. Curr Radiol Rep 3, 35 (2015). https://doi.org/10.1007/s40134-015-0113-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40134-015-0113-0

Keywords

Navigation